Owonikoko, Taofeek, Kyriakos Papadopoulos, Melissa Johnson, and et al. 2019. “Phase 1 Study of Cemiplimab, a Human Monoclonal Anti-PD-1 Antibody, in Patients With Unresectable Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-up Efficacy and Safety Data”. SKIN The Journal of Cutaneous Medicine 3 (2):169. https://doi.org/10.25251/skin.3.2.9.